DK297285A - Fremstilling af heterodimere humane fertilitetshormoner ved rekombinant metodologi - Google Patents

Fremstilling af heterodimere humane fertilitetshormoner ved rekombinant metodologi Download PDF

Info

Publication number
DK297285A
DK297285A DK297285A DK297285A DK297285A DK 297285 A DK297285 A DK 297285A DK 297285 A DK297285 A DK 297285A DK 297285 A DK297285 A DK 297285A DK 297285 A DK297285 A DK 297285A
Authority
DK
Denmark
Prior art keywords
preparation
recombinant methodology
hormone
human fertility
subunit
Prior art date
Application number
DK297285A
Other languages
English (en)
Other versions
DK297285D0 (da
Inventor
Vemuri B Reddy
Nancy Hsiung
Anton K Beck
Edward George Bernstine
Original Assignee
Vemuri B Reddy
Nancy Hsiung
Anton K Beck
Edward George Bernstine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24187868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK297285(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US1984/001766 external-priority patent/WO1985001958A1/en
Application filed by Vemuri B Reddy, Nancy Hsiung, Anton K Beck, Edward George Bernstine filed Critical Vemuri B Reddy
Publication of DK297285A publication Critical patent/DK297285A/da
Publication of DK297285D0 publication Critical patent/DK297285D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/60Vector systems having a special element relevant for transcription from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)
DK297285A 1983-11-02 1985-07-01 Fremstilling af heterodimere humane fertilitetshormoner ved rekombinant metodologi DK297285D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54821183A 1983-11-02 1983-11-02
PCT/US1984/001766 WO1985001958A1 (en) 1983-11-02 1984-10-31 Production of heterodimeric human fertility hormones

Publications (2)

Publication Number Publication Date
DK297285A true DK297285A (da) 1985-07-01
DK297285D0 DK297285D0 (da) 1985-07-01

Family

ID=24187868

Family Applications (2)

Application Number Title Priority Date Filing Date
DK297185A DK171489B1 (da) 1983-11-02 1985-07-01 Fremgangsmåde til fremstilling af et biologisk aktivt, posttranslationelt modificeret proteinhormon sammensat af flere underenheder, eukaryotisk celle, som er transficeret med en eller flere udtrykkelsesvektorer og er i stand til at producere et sådant hormon, udtrykkelsesvektor omfattende heterolog DNA, som koder for underenhederne af hormonet, et sæt af udtrykkelsesvektorer, hvor hver vektor omf
DK297285A DK297285D0 (da) 1983-11-02 1985-07-01 Fremstilling af heterodimere humane fertilitetshormoner ved rekombinant metodologi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK297185A DK171489B1 (da) 1983-11-02 1985-07-01 Fremgangsmåde til fremstilling af et biologisk aktivt, posttranslationelt modificeret proteinhormon sammensat af flere underenheder, eukaryotisk celle, som er transficeret med en eller flere udtrykkelsesvektorer og er i stand til at producere et sådant hormon, udtrykkelsesvektor omfattende heterolog DNA, som koder for underenhederne af hormonet, et sæt af udtrykkelsesvektorer, hvor hver vektor omf

Country Status (8)

Country Link
EP (3) EP0578328B1 (da)
AT (2) ATE190461T1 (da)
DE (4) DE10199035I2 (da)
DK (2) DK171489B1 (da)
LU (1) LU90770I2 (da)
MX (1) MX9203334A (da)
NL (1) NL300044I2 (da)
WO (1) WO1985001959A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
JPS60145098A (ja) * 1984-01-09 1985-07-31 Suntory Ltd 糖付加ポリペプチドの製造法
WO1986007383A1 (en) * 1985-06-04 1986-12-18 Biotechnology Research Partners, Ltd. Autoantigen vaccines
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells
US5648254A (en) * 1988-01-15 1997-07-15 Zymogenetics, Inc. Co-expression in eukaryotic cells
US5705478A (en) * 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
US6225449B1 (en) 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
EP0461200B1 (en) * 1989-02-21 1997-01-22 Washington University Modified forms of reproductive hormones
US5792460A (en) * 1989-02-21 1998-08-11 Washington University Modified glycoprotein hormones having a CTP at the amino terminus
US6028177A (en) * 1991-10-04 2000-02-22 Washington University Methods of detecting single-chain forms of the glycoprotein hormone quartet
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US6737515B2 (en) 1993-11-19 2004-05-18 Washington University Follicle stimulating hormone-glycosylation analogs
US6238890B1 (en) 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
MX9601320A (es) * 1994-08-12 1997-05-31 Univ Washington Formas de cadena unica de cuarteto de hormona de glicoproteina.
DK0725795T3 (da) * 1994-08-12 2004-05-17 Univ Washington Enkelt-kæde form af glycoprotein-hormon-kvartetten
US6635256B1 (en) 1998-10-19 2003-10-21 Washington University Glycoprotein hormone compositions comprising two β subunits and methods of use thereof
US6103501A (en) * 1997-11-17 2000-08-15 Washington University Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
EP1013281A1 (en) 1998-12-15 2000-06-28 Applied Research Systems ARS Holding N.V. hCG therapy for the treatment of breast cancer
JP2002541213A (ja) 1999-04-13 2002-12-03 インヘール セラピューティック システムズ, インコーポレイテッド 不妊症の処置のための乾燥粉末処方物の肺投与
JP2005509652A (ja) * 2001-11-08 2005-04-14 モイル,ウィリアム,アール 蛋白質の瘤
US7081446B2 (en) 2002-01-31 2006-07-25 The Trustees Of Columbia University In The City Of New York Long-acting follicle stimulating hormone analogues and uses thereof
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
EA200800755A1 (ru) 2005-09-07 2008-10-30 Лаборатуар Сероно С.А. Ikk ингибиторы, предназначенные для лечения эндометриоза

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2048894A (en) * 1979-05-11 1980-12-17 Gist Brocades Nv Plasmid
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations

Also Published As

Publication number Publication date
DE3486469T2 (de) 1999-04-15
LU90770I2 (fr) 2001-07-03
ATE169334T1 (de) 1998-08-15
MX9203334A (es) 1992-09-01
EP0578328B1 (en) 1999-12-29
EP0160699A1 (en) 1985-11-13
DK171489B1 (da) 1996-11-25
WO1985001959A1 (en) 1985-05-09
DE3486469D1 (de) 1998-09-10
DE3486474D1 (de) 2000-02-03
DK297185A (da) 1985-07-01
DK297185D0 (da) 1985-07-01
EP0160699B1 (en) 1992-08-12
EP0578328A1 (en) 1994-01-12
NL300044I2 (nl) 2001-12-01
DE10199028I1 (de) 2001-09-20
ATE190461T1 (de) 2000-04-15
NL300044I1 (nl) 2001-07-02
EP0957167A1 (en) 1999-11-17
DE10199035I1 (de) 2001-11-08
DE10199028I2 (de) 2004-07-01
EP0160699A4 (en) 1987-10-20
DE10199035I2 (de) 2006-03-16
DK297285D0 (da) 1985-07-01
DE3486474T2 (de) 2000-08-03

Similar Documents

Publication Publication Date Title
DK297285D0 (da) Fremstilling af heterodimere humane fertilitetshormoner ved rekombinant metodologi
US4780451B1 (en) Composition and method for producing superovulation in cattle
AR013201A1 (es) Proteina interleuquina-6 receptor interleuquina-6 quimerica soluble, analogos de la misma, una secuencia de adn, un vector de adn, celulas de mamifero transformadas incapaz de generar un animal, un metodo para producir una proteina quimerica, la utilizacion de dicha proteina para la preparacion de u
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
DK150146C (da) Analogifremgangsmaade til fremstilling af somatostatinanaloge hepta- eller octapeptider eller salte eller complexer deraf
DK463586A (da) Fsh
DK645887D0 (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
ES529666A0 (es) Procedimiento para preparar mezclas de hormona foliculo-estimulante y hormona luteinizante de la hipofisis del cerdo en una proporcion determinada
DK1339855T3 (da) Forbedring af homogenitet og sekretion af rekombinante proteiner i pattedyrsystemer
DK0751782T3 (da) Anvendelse af et ikke-neutraliserende antistof, som er specifikt for beta-subunit'en i luteiniserende hormon, til forbedring af fertilitet
FI811682L (fi) Lh-rh antagonister
KR900702048A (ko) 고나도트로핀 및 그에 의한 과할성 작용제의 제조 방법
EP0178867A3 (en) Novel hormones and methods for making, using and assaying same
ATE177474T1 (de) Rekombinanter impfstoff zur geburtenkontrolle
Shiota et al. MATERNAL CONTROL OF PLACENTAL LACTOGEN (S) SECRETION: EVIDENCE FOR EXTRA-PLACENTAL REGULATION
Cuny Effects of mammalian pituitary hormone preparations on the cultured newt iris: stimulation of lens regeneration by some thyrotropin preparations
Bousfield Purification and in vitro biological characterization of equine and chicken gonadotropins: Demonstration of intrinsic FSH activity of equine and chicken LH in the rat
Iida Japan's Space Development Programs for Communications: An Overview
Sandusky Jr et al. Application of the peroxidase-antiperoxidase procedure to the localization of pituitary hormones and calcitonin in various domestic animals and human beings.
SHIELDS Human operator performance of remotely controlled tasks: Teleoperator research conducted at NASA's George C. Marshall Space Flight Center. Executive summary[Summary Report, 1971- 1981]
Hoffmann-Ostenhof et al. Nomenclature of peptide hormones. IUPAC-IUB [International Union of Pure and Applied Chemistry-International Union of Biochemistry] Commission on Biochemical Nomenclature Recommendations (1974)

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment